Semaglutide and the future of obesity care in the UK

Lancet. 2023 Jun 24;401(10394):2093-2096. doi: 10.1016/S0140-6736(23)01083-8. Epub 2023 Jun 5.
No abstract available

MeSH terms

  • Glucagon-Like Peptides* / therapeutic use
  • Humans
  • Obesity* / epidemiology
  • United Kingdom

Substances

  • semaglutide
  • Glucagon-Like Peptides